Skip to main content
. 2020 Nov 4;246(5):584–595. doi: 10.1177/1535370220967325

Figure 3.

Figure 3.

A schematic overview of the studies involved in RRA analysis (51/39 is the number of Parkinson’s disease patients and healthy controls in the original study respectively), the output DEGs and KEGG pathways, and the overlap between the investigated studies.